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Rhesus monkey rhadinovirus (RRV) is a 2-herpesvirus identified from the peripheral blood mononuclear cells of rhesus
macaques (Macaca mulatta). Serologic studies suggested that the infections of RRV are prevalent among rhesus monkeys.
RRV can be efficiently propagated and grows to a high titer in cultured rhesus monkey fibroblasts, thus providing a valuable
model to study the rhadinovirus replication. By comparative genomic studies, here we describe the identification of two
potential transcriptional factors encoded by RRV, designated as R-Rta and R-bZIP. Initial functional characterization of these
products suggested that R-Rta is a potent transcriptional activator and R-bZIP forms homodimers in vivo. Viral homologues
of R-Rta and R-bZIP, previously identified from other rhadinoviruses, have been implicated in serving as molecular switchesIntroduction. Rhesus monkey rhadinovirus (RRV) was
first suggested by ELISA results which showed that sera
from the old world rhesus monkeys (Macaca mulatta)
cross-reacted with a new world primate herpesvirus,
herpesvirus saimiri (HVS) (5). Further examination indi-
cated that infection with a new agent, designated
RRV26-95 and distinct from HVS, was highly prevalent in
rhesus monkeys at three independent colonies (5, 14).
Although experimental infection of rhesus monkeys or
pig-tailed macaques (Macaca nemestrina) with RRV has
not yet shown consistent association with specific dis-
orders, lymphoproliferative disease and arteriopathy
have been reported in monkeys dually infected with RRV
and simian immunodeficiency virus (14, 24). Kaposi’s
sarcoma (KS)-associated herpesvirus (KSHV, or human
herpesvirus 8, HHV8) was first identified from a KS lesion
in an HIV-infected individual, followed by the subsequent
recognition of KSHV in primary effusion lymphoma (PEL)
and multicentric Castleman’s disease (MCD) (reviewed
in (3)). Infection with KSHV is prevalent in HIV-infected
homosexual men, adults of both sexes in Africa, and
elderly men of Eastern European or Mediterranean ori-
gin. Whether KSHV is a leading cause, or a coactivator of
KS pathogenesis, is presently unresolved.
Molecular studies of KSHV have been greatly ad-
1 To whom correspondence and reprint requests should be ad-181vanced by the establishment of a number of PEL lines in
vitro. KSHV remains dormant in these cells, but can be
reactivated by treatment with agents such as phorbol
ester (e.g., TPA) or sodium butyrate (15, 17, 18). Upon
reactivation, the earliest transcript detected in the KSHV
lytic stage is a 3.8-kb bicistronic mRNA which potentially
encodes two transcriptional factors, variously known as
KSHV Rta or ORF50 and K-bZIP or K8 (8, 10, 11, 21). An
abundant 1.35-kb monocistronic mRNA encoding K-bZIP
is also readily detected in the early phase of KSHV lytic
replication; this viral transcript appears about 3–4 h later
than that of the 3.8-kb bicistronic species (10, 22). At
present, at least three Rta-responsive elements have
been identified which are all located in the upstream
sequences of the early-lytic genes, namely ORF57, K-
bZIP, and polyadenylated nuclear RNA (11, 20, 23). In
addition, when provided ectopically, Rta alone can dis-
rupt the viral latency in the KSHV-infected PEL cells (11,
21). These results suggested that KSHV Rta may function
as a “molecular switch” which activates the lytic-cycle
replication of dormant KSHV. The biological role of K-
bZIP is much less clear, yet it bears substantial posi-
tional and structural similarities to EBV BZLF1 (a.k.a.
ZEBRA, Zta, EB1), one of the two molecular switches in
EBV latency (16).
Comparative genomic studies of RRV, KSHV, and Ep-
stein–Barr virus (EBV), three phylogenically related 2
herpesviruses (1, 2, 18, 19), suggested that RRV equiva-in lytic replication. © 2002 Elsevier Science (USA)
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lents of Rta and bZIP proteins should be within a con-
served genomic region, ORF50–ORF8.1. Additionally, in
0042-6822/02 $35.00; RNA s© 2002 Elsevier Science (USA)
All rights reserved.
EBV and KSHV the transcripts originating from those loci
often undergo complicated splicing events (4, 10, 13, 21);
thus, even with the genome sequences completely de-
termined, the precise nucleotide coordinates of RRV
ORF50, ORF8, and ORF8.1 were not previously assigned
(1, 19). In this communication, by using rapid analysis of
cDNA ends (RACE) and reverse transcription–polymer-
ase chain reaction (RT-PCR) approaches, we describe
the cloning and transcriptional mapping of mRNAs tran-
scribed from this region.
Results. Molecular cloning of R-Rta and R-bZIP. The
full-length cDNAs of the RRV gene products were pre-
pared from primary monkey fibroblasts which had been
infected with RRV26-95 for 72 h. RACE analysis was
carried out by using oligonucleotides whose correspond-
ing genomic locations are illustrated in Figs. 1A and 1B.
The 5 and 3 end sequences of the RACE products were
determined and end primers were designed to amplify
the full-length cDNAs for R-Rta and R-bZIP via RT-PCR
(Fig. 1C). The nucleotide sequences of the full-length
FIG. 1. Transcriptional mapping of R-Rta and R-bZIP. (A) Schematic drawings of the genomic locations of ORF49, 50, R8, and R8.1. The denoted
nucleotide coordinates are according to Ref. (1) and the ORFs are scaled. Two polyadenylation signals (AATAAA) are depicted. (B) Primers used in
the 5 and 3 RACE analyses. Primer orientation is depicted by arrows. (C) Primers used in the RT-PCR reactions. Specifically, primers 1 and 2 were
used in the cloning of full-length R-Rta cDNA; primers 3 and 4 were used in the cloning of full-length R-bZIP cDNA. (D) Schematic drawings of the
transcription/splicing patterns of R-Rta and R-bZIP. Exons identified in the present study are depicted in gray boxes (with arrow pointing to the
translation direction). Two hypothetical transcripts (RRtaRbZIP and RbZIP) are shown beneath the drawing with introns depicted by thin, joined lines.
Potential promoter sequences of R-Rta and R-bZIP predicted from the 5RACE analyses are denoted in shaded boxes and designated R-Rta(p) and
R-bZIP(p), respectively. (E) Northern analysis of R-Rta and R-bZIP transcripts. Ten micrograms of total RNA isolated from rhesus monkey fibroblasts
(lanes 1, 4), fibroblasts infected with RRV for 24 h (lanes 2, 5) or 72 h (lanes 3, 6) were subjected to Northern analysis by using R-Rta sequences (left)
or R-bZIP sequences (right) as probes. Cellular 28S rRNAs of each sample were visualized by ethidium bromide staining. The genomic coordinates
of each probe are depicted in accordance with the drawings in (A) and (D). The potential bicistronic-transcripts (RRtaRbZIP) depicted in (D) can be
referred to the 4,4- and 3.4-kb transcripts and are detected by using either R-Rta or R-bZIP as a probe. The 4.4-kb transcript may represent an
intermediately processed mRNA in which the ORF 49 is not yet removed. Similarly, the difference between the 1.1- and the 0.85-kb RbZIP transcripts
may result from the presence or absence of intervening sequences (IVS) in the transcript. The nature of the 2.5-kb transcript in the R-Rta blot is
discussed in the text.
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cDNAs for R-Rta and R-bZIP were then determined and
compared to the corresponding genomic sequences.
Both the R-Rta and the R-bZIP cDNAs are produced
through splicings (Fig. 1D). To further define the tran-
scriptional pattern of R-Rta and R-bZIP, DNA fragments
derived from the cDNA clones were used as probes in
Northern analysis of the rhesus fibroblasts infected with
RRV (Fig. 1E). A 3.4-kb transcript was detected in RNAs
prepared from cells infected with RRV, when either R-Rta
or R-bZIP was used as a probe. By analogy to KSHV and
EBV, this is likely the bicistronic transcript carrying both
R-Rta and R-bZIP ORFs. The 0.85-kb transcript which
hybridized only to the R-bZIP probe corresponds to the
monocistronic R-bZIP transcript. The 4.4-kb and 1.1-kb
transcripts are likely the splicing intermediates with the
former being the precursor (ORF49 unspliced) of the
3.4-kb transcript, and the latter being the precursor of the
0.85-kb transcript. These data substantiate the results
described in the RACE and RT-PCR analysis. Interest-
ingly, R-Rta probe detected a 2.5-kb transcript which may
account for a splicing variant of R-Rta or a novel tran-
script derived from the opposite strand of R-Rta. Further
experiments are needed to define the nature of this
transcript. In summary, by RACE and RT-PCR we have
delineated the transcriptional patterns of RRV Rta and
bZIP in the viral genome. The transcriptional strategies
used by RRV and KSHV appear to be quite similar. The
structural comparisons and initial functional character-
izations of these gene products are described below.
The Structure and Transactivation Potential of R-Rta.
As depicted in Fig. 1D, the R-Rta transcript undergoes
one splicing, skipping ORF49. The resulting R-Rta ORF
consists of 577 aa, which exhibits an overall 53% simi-
larity to the amino acid sequence of KSHV Rta (Fig. 2A).
Interestingly, the N-terminal 300 amino acids of these
two proteins share significantly higher homology (78%)
than the C-terminal domain (30%). Recent data suggest
that the N-terminal domain of K-Rta is involved in DNA
binding, whereas the C-terminal domain contains trans-
activation activity (9, 12, 23). There are several notable
features well-conserved between R-Rta and K-Rta: (1) the
two nuclear localization signals (NLS) located, respec-
tively, in the N- and C-termini; (2) the leucine-zipper-like
motif is preceded by a stretch of conserved residues,
presumably involved in oligomerization (12); and (3) the
C-terminal transcriptional activation domain (TA) is com-
posed of characteristic bulky hydrophobic and acidic
residues. Together, these features provide suggestive
evidence that R-Rta, similar to its homologues, may also
be a potent transcriptional factor.
As described above, KSHV Rta is considered an im-
mediately-early gene which functions to induce the ex-
pression of a number of downstream viral molecules
such as K-bZIP and ORF57 (6, 11, 21, 26). As an initial test,
we asked whether R-Rta also behaves similar to a tran-
scriptional factor, and if so, whether it transactivates the
R-bZIP promoter. In the absence of antibodies against
these gene products, the full-length R-Rta was tagged
with a HA epitope sequence at the N-terminus and
cloned into a mammalian expression vector, pcDNA3.1.
As shown in Fig. 2B, upon transfection into COS1 cells, a
distinct band with an estimated molecular weight of 73
kDa was detected by using HA-tag monoclonal antibod-
ies in a Western blot analysis of whole-cell extracts. As a
control, this band is absent in vector (pcDNA3.1)-trans-
fected cells. We then developed a reporter plasmid for
R-bZIP promoter. This was accomplished by inserting the
upstream sequences of R-bZIP (306 bp from the 5 end of
R-bZIP ORF, Fig. 1D) to the front of a firefly luciferase
gene in pGL3-Basic, yielding a construct dubbed
RbZIP(p)-Luc. RbZIP(p)-Luc was then cotransfected with
HA-RRta into HEK293, a cell line with high transfection
efficiency yet low background of luciferase activity. Lu-
ciferase activity assays were performed 48 h after trans-
fection and, as shown in Fig. 2C (left), R-Rta exhibits a
50-fold activation activity on R-bZIP promoter, compared
to that of the vector control. This result provided the first
evidence that R-Rta is a potent transcriptional factor.
Since the DNA-binding domains of R-Rta and K-Rta share
significant homology, we asked whether R-Rta is able to
activate K-bZIP promoter, as a lytic promoter effectively
responds to K-Rta. A two-fold activation of KbZIP(p)-Luc
was observed. This level of activation is about one-
hundredth of that induced by the homologous K-Rta (data
not shown). This result suggests that R-Rta recognition
elements may differ from those of K-Rta. Alternatively,
R-Rta may still recognize the K-bZIP promoter, yet, coac-
tivators recruited by the TA domain of R-Rta are not
sufficient to support a full transactivation on K-bZIP pro-
moter sequences. Together, these results provided the
first evidence that R-Rta is a potent transcriptional factor,
similar to its counterpart in KSHV. Whether R-Rta also
plays a key role in the disruption of latency awaits the
derivation of cell lines harboring latent RRV genome.
The Structure and Dimerization Potential of R-bZIP. As
shown in Fig. 1D, immediately downstream from the Rta
gene is the R-bZIP coding sequence. The R-bZIP tran-
script undergoes two splicing events. The resulting ORF
is 234 aa in size and shares a 37% similarity to the amino
acid sequence of KSHV K-bZIP (Fig. 3A). It also seems to
have a bipartite structure in this pairwise alignment: the
C-terminal domain shares significantly more homology
(51%) than the N-terminal part (24%). Similar to K-bZIP, the
C-terminal domain of R-bZIP is characterized by a pro-
totypic bZIP domain (leucine zipper domain preceded by
a basic region; Fig. 3A). The ZIP domain contains a
stretch of heptad-repeat of hydrophobic/long side-chain
residues, which are predicted to constitute a coiled–
coiled domain involved in dimerization (7). In the case of
R-bZIP, the heptad repeats are spaced as L, K, L, L, L, M,
as depicted in Fig. 3A. The basic region of R-bZIP is 30%
arginine or lysine residues, as compared to 22% in K-
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FIG. 2. Structure and transactivation potential of R-Rta. (A) Pairwise alignments of K-Rta and R-Rta. Amino acid sequences of R-Rta deduced from
the full-length cDNA was compared to those of K-Rta (21) by using the ClustalW program of MacVector 6.5.3 (Oxford Molecular group). Conserved
residues are shaded dark-gray (identical) or light-gray (similar). The overall similarity between K-Rta and R-Rta is 53%. Since significantly larger
numbers of conserved residues are located in the N-terminus of the alignment, the respective similarities in the N-terminal half and the C-terminal
half are depicted in the top panel. NLS, putative nuclear localization signal. Exon/intron junctions are denoted by solid triangles. Basic residues are
marked by stars, and the heptad repeat assignments conceded with the zipper specifications are indicated by arrows. (B) Expression of HA-tagged
R-Rta in mammalian cells. Total protein extracts from COS1 cells transfected with pcDNA3.1 (Vector) or pHA-R-Rta (HA-RRta) were recovered,
subjected to Western blot analysis, and probed with antibodies against HA-tag. The filter was developed by the enhanced chemiluminescence (ECL)
method. To standardize the protein quantity in each lane, the filter was subsequently stripped and reprobed with antibodies against -actin as
illustrated on the bottom of the gel (actin). A prominent 70-kDa band beneath the predicted HA-R-Rta polypeptide was attributed to a crossreactivity
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of the HA-tag antibodies against cellular protein(s) of COS1. (C) Luciferase reporting gene assays of R-Rta transcription activity. HEK 293 cells were
cotransfected with reporter plasmids (RbZIP(p)-Luc (left panel); KbZIP(p)-Luc (right panel)) and transactivator plasmids (pcDNA3.1 (Vector); pHA-R-Rta
(RRta)). Forty-eight hours after transfection, cells were lysed and luciferase activities were measured by microplate luminometer (EG&G BERTHOLD).
Relative luciferase unit (RLU) for each set of constructs was obtained from three independent experiments and was converted to induction fold by
setting the RLU of vector control to 1.
FIG. 3. Structure and dimerization potential of R-bZIP. (A) Pairwise alignment of K-bZIP and R-bZIP. Amino acid sequences of R-bZIP deduced from
the full-length cDNAs were compared to those of K-bZIP (10) by using the ClustalW program of MacVector 6.5.3 (Oxford Molecular group). Conserved
residues are shaded dark-gray (identical) or light-gray (similar). The overall similarity between K-bZIPa and R-bZIP is 37%. The respective similarities
in the N-terminus and the bZIP domain are depicted in the top panel. Exon/intron junctions of each sequence are denoted by solid triangles. Basic
residues are marked by asterisks, and the heptad repeat assignments conceded with the zipper specifications are indicated by arrows. (B) R-bZIP
forms dimers in vivo. Cellular protein extracts from COS1 cells transfected with pcDNA3.1 (Vector), pHA-R-bZIP (HA-RbZIP), pT7-R-bZIP (T7-RbZIP), or
both pHA-R-bZIP and pT7-bZIP were recovered and quantitated, and equal amounts were used in each reaction. Immunoprecipitation (IP) assays
were performed by the incubation of protein lysates with monoclonal antibodies against HA-tag and captured by protein G–Sepharose mixture.
Protein samples of total cell lysates (lanes 1–4) or from IP (lanes 5–8) were subjected to Western blot analysis and probed with antibodies against
T7-tag. Both filters were developed by the enhanced chemiluminescence (ECL) method. The total lysate blot was further stripped and reprobed with
antibodies against -actin to ensure equal amounts of protein were loaded in each lane (-actin). (C) R-bZIP does not form heterodimers with K-bZIP
in vivo. Cellular protein extracts from COS1 cells transfected with pT7-R-bZIP plus pcDNA3.1 (lanes 1, 4), plus pHA-R-bZIP (lanes 2, 5), or plus
pHA-K-bZIP (lanes 3, 6), were recovered, quantitated, and equalized to the same amount in each reaction. IP assays were performed by the incubation
of protein lysates with monoclonal antibodies against T7-tag and captured by protein G–Sepharose mixture. The supernatant portion (lanes 1–3) and
the precipitate portion (lanes 4–6) of each IP reaction were separated by centrifugation and subjected to Western blot analysis by using HA-tag as
primary antibodies. The amount of T7-RbZIP protein used in each IP was examined by Western analysis of a total lysate blot with T7-tag antibodies
(-T7-RbZIP).
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bZIP, which presumably functions as both DNA-binding
domain and nuclear localization signal (7). Many cellular
and herpesviral bZIP proteins, such as jun, fos, EBV
BZLF1, and Marek’s disease virus (MDV) Meq, are tran-
scriptional factors. At present, there is no evidence es-
tablishing K-bZIP as either a transcriptional factor or a
DNA-binding protein, although a role in replication has
been implicated (25). Despite the lack of a definitive
biological function ascribed to K-bZIP, we knew that
K-bZIP forms a strong homodimer through its ZIP domain
(10). We therefore asked whether R-bZIP also forms a
homodimer. R-bZIP was differentially tagged, either with
the HA or with the T7 epitope sequence at the N-termi-
nus. These two constructs were coexpressed in the
COS1 cell. If homodimers formed, coprecipitation of HA-
R-bZIP and T7-R-bZIP would be expected. As shown in
Fig. 3B, total cell extracts (lanes 1–4) were first immuno-
precipitated (IP) with HA antibody (lanes 5–8), followed
by Western blot analysis with T7 antibody. T7 antibody
failed to detect R-bZIP in the cell lysates of vector-
transfected (lane 1), HA-R-bZIP-transfected (lane 2); the
HA antibody precipitates of vector-transfected (lane 5),
HA-R-bZIP-transfected (lane 6), and of T7-R-bZIP trans-
fected cells (lane 7); these results established the spec-
ificity of the antibodies used. An intense band, corre-
sponding to T7-R-bZIP, was however readily detected in
the cell lysates of T7-R-bZIP-transfected (lane 3) and
cotransfected (lane 4) cells and the HA immunoprecipi-
tates of cells cotransfected with HA-R-bZIP and T7-R-
bZIP (lane 8), demonstrating that R-bZIP does form dimer
structures. This conclusion was further reinforced by the
reciprocal experiment where T7 antibody was used to
immunoprecipitate the complex, followed by Western
blotting to detect the HA-R-bZIP (data not shown). The
above data provide evidence that R-bZIP forms ho-
modimers in vivo. Due to the similarity of R-bZIP and
K-bZIP in the bZIP domain, we asked whether these two
molecules form a heterodimer. As shown in Fig. 3C,
using T7-tagged R-bZIP as bait, only HA-tagged R-bZIP,
but not HA-tagged K-bZIP could be pulled down by T7-
R-bZIP (lane 5). HA-K-bZIP was retained in the superna-
tant fraction of the IP reaction (lane 3). Previously, we
showed that K-bZIP can only form homodimers but not
heterodimers with jun, fos, or other bZIP proteins. It thus
seems that the bZIP domains of rhadinoviral bZIP pro-
teins are rather specific for homodimerization. Of note,
both R-bZIP and K-bZIP exhibited anomaly electro-
phoretic mobility (34 kDa for the 234-aa R-bZIP and 42
kDa for the 237-aa K-bZIP) which may be due to high Gln
(R-bZIP 7.7%, K-bZIP 6.3%), high Pro (K-bZIP 10.1%), or
protein phosphorylation (R-bZIP Ser/Thr 17.2%, K-bZIP
Ser/Thr 15.5%).
Discussion. In summary, by RACE and RT-PCR ap-
proaches we have identified in the RRV26-95 genome
two gene products, R-Rta and R-bZIP, whose transcrip-
tional regulation undergoes complicated RNA splicing
processes. Biological features of R-Rta and R-bZIP were
explored based on the best known properties of their
respective KSHV equivalents. We established that R-Rta
is a potent transactivator that acts on the R-bZIP pro-
moter; R-bZIP forms dimers itself, but not with K-bZIP
when both are present. These results suggest that the
general pattern of transcriptional regulation of RRV and
KSHV may be the same. Further comparative studies of
RRV and KSHV would not only help to elucidate the
common viral replication strategies, but also reveal the
differences which are responsible for the disease pro-
gression and the programs of host–viral interaction. The
successful cloning and identification of these sequences
of R-Rta and R-bZIP thus provide a basic framework to
conduct such comparative studies.
Materials and Methods. Rapid amplification of cDNA
ends. To isolate full-length cDNA for the RRV gene prod-
ucts, RRV26-95 virus was grown in primary rhesus mon-
key fibroblasts (5), and total RNAs were prepared from
cells 72 h after infection. The RACE assays were essen-
tially referred to the procedures described previously (10)
with the following modifications. Specifically, polyadenyl-
ated RNA (poly(A) RNA) was purified using oligo(dT)
cellulose (type 7, Pharmacia, NJ) spin columns. Two and
one-half micrograms of poly(A) RNA was primed with
SS-dT oligonucleotides (CGTAGGTTACCGTATCGGAT-
AGCGGCCGCATTTTTTTTTTTTTTTTTT) for 3RACE or
dT20 for 5RACE, and reverse transcription was carried
out using AMV-reverse transcriptase (Boehringer Mann-
heim, IN) at 42°C for 1 h using the conditions specified
by the manufacturer. The resulting first-strand cDNA was
used directly as DNA template in 3RACE. DNA template
for 5RACE was prepared by further treatment of the
first-strand cDNA with 60 U terminal deoxynucleotidyl
transferase (GIBCO BRL, MD) in the presence of 0.2 mM
dATP for 15 min at 37°C. The second-strand synthesis
was then primed with SS-dT primer and incubated with
120 U T4 DNA polymerase, 24 U Escherichia coli DNA
ligase, 5 U RNaseH in a buffer containing 0.2 mM dNTP,
100 mM KCl, 10 mM ammonium sulfate, 5 mM MgCl2,
0.15 mM  NAD, 20 mM Tris–HCl pH 7.5, and 50 g/ml
BSA for 4 h at 15°C. PCR conditions for denaturation,
annealing, and polymerization were 94°C 50 s, 56°C 1
min, and 68°C 3 min. High-fidelity Taq polymerase
(Boehringer Mannheim) was used in all the RACE assays
and 30 cycles of amplification were applied to each
reaction. PCR products were subsequently cloned into
the pCR 2.1-TOPO vector (Invitrogen, CA). The DNA se-
quence of each insert was determined on both strands
by a dideoxynucleotide chain termination method.
DNA and Protein Sequences Analysis. DNA se-
quences of RACE clones were compiled, aligned, and
analyzed using Mac Vector 6.5.3 (Oxford Molecular
group). Deduced amino acid secondary structures were
analyzed by Chou-Fasman, Kyte-Doolittle, or Robson-
Garnier programs. Alignment of consensus sequences
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between K-Rta and R-Rta and K-bZIP and R-bZIP were
performed by ClustalW analysis. The cDNA sequences
of R-Rta and R-bZIP have been deposited in GenBank
under Accession Nos. AF241163 and AF241164, respec-
tively.
Immunoprecipitation and Western Immunoblot Analy-
sis. Immunoprecipitation was performed as described
(10). Briefly, cells were rinsed in ice-cold PBS and lysed
in RIPA buffer with protease inhibitors (50 mM Tris–HCl
pH 8.0, 150 mM NaCl, 1% NP-40, 0.5% deoxycholate, 0.1%
SDS, 1 mM PMSF, 1 g/ml pepstatin A, 0.2 U/ml aproti-
nin, 0.5 g/ml leupeptin). Two hundred micrograms of
cell lysates were cleared by centrifugation and mixed
with 1–2 g monoclonal antibodies against HA (BABCO,
CA) or T7 (Novagen, WI) tags for 2 h at 4°C with gentle
rotation. The immunocomplex was then captured by add-
ing a protein A and protein G–Sepharose mixture
(Zymed, CA) and rocked for an additional 2 h. Beads
were washed three times in RIPA and then boiled for 10
min in 60 l 2 SDS sample buffer (125 mM Tris–HCl, pH
6.8, 4% SDS, 2 mM EDTA, 20% glycerol, 0.6% bromophe-
nol blue). Protein samples from total cell lysates or im-
munoprecipitations were resolved by 10% SDS–PAGE
and then transferred to PVDF membranes (Biotechnol-
ogy System, Boston, MA) using a semidry apparatus
(Pharmacia). After blocking in TBST/BSA (20 mM Tris–
HCl, pH 7.6, 137 mM NaCl, 1% Tween-20, 5% BSA) for 1 h
at room temperature, the filters were incubated with
primary antibodies (1:1500 dilution) for 2 h at room tem-
perature. Filters were subsequently washed in TBST
three times for 10 min each. After washing, the filters
were incubated with HRP-conjugated goat anti-mouse
antibodies (1:2000 dilution) for 1 h, washed three times
with TBST, and then developed using enhanced chemi-
luminescence (ECL) reagents (Amersham, IL).
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